Loading...
Market
What will be the market share status of the new over-the-counter COVID-19 and flu test by December 31, 2024?
2
Resolution / Starting Odds
New test leads market • 25%
Existing tests maintain dominance • 25%
Market share evenly distributed • 25%
Other outcome • 25%
Market analysis reports from companies like Nielsen or IRI
Story
FDA Authorizes First Over-the-Counter COVID-19 and Flu Test on Monday
Oct 8, 2024, 04:23 PM
The U.S. Food and Drug Administration (FDA) has granted marketing authorization for the first over-the-counter combination COVID-19 and flu test outside of emergency use on Monday. This test, which uses a nasal swab sample, is intended for individuals experiencing respiratory symptoms and can be used at home to deliver results for both COVID-19 and flu. This authorization marks a significant step as it joins other over-the-counter COVID-19/flu tests that were previously available only under emergency use authorization.
View original story
Similar markets
Less than 20% • 25%
20% to 40% • 25%
40% to 60% • 25%
More than 60% • 25%
Manufacturer A has largest share • 25%
Manufacturer B has largest share • 25%
Manufacturer C has largest share • 25%
Manufacturer D or others have largest share • 25%
Manufacturer A • 25%
Manufacturer B • 25%
Manufacturer C • 25%
Other • 25%
Less than 20% • 25%
20% to 40% • 25%
40% to 60% • 25%
More than 60% • 25%
Yes • 50%
No • 50%
Walmart • 25%
CVS • 25%
Walgreens • 25%
Amazon • 25%
None • 25%
1 to 2 • 25%
3 to 4 • 25%
More than 4 • 25%